Problems with Pradaxa Becoming Widely Discussed
Pradaxa and Xarelto are anticoagulant medications intended to prevent strokes in patients with non-valvular atrial fibrillation by inhibiting blood from clotting. However, in some cases such as internal bleeding or accidental cuts, the failure of blood to clot can be fatal. Many patients have allegedly experienced life-threatening problems with Pradaxa, such as severe gastrointestinal bleeding or cerebral hemorrhage because there is currently no known antidote or reversal agent to counteract the effects of the medication. What begins as a simple cut from household chores may result in uncontrollable bleeding.
Problems with Pradaxa Include Lack of Antidote
At a seminar organized by the Cardiac Safety Research Consortium and the U.S. Food and Drug Administration, a cardiologist from Lankenau Heart Institute in Wynnewood, Pennsylvania stated that 200,000 patients out of the six million taking outpatient anticoagulants are hospitalized for bleeding complications each year in the U.S. Of these, 65,000 patients are taking new oral anticoagulants.
While Pradaxa was initially intended to replace the well-known anticoagulant warfarin, excessive bleeding from which can be reversed with a vitamin K injection, the percentage of patients that report internal bleeding with warfarin is around three percent annually. This rate is only slightly lower than that of Xarelto and Pradaxa, and as such, a Duke cardiologist at the same seminar maintained that it is more important to stop the intracranial hemorrhage and trauma before they begin and not necessarily create an antidote for the medications.
Plaintiffs File Lawsuits Alleging Problems with Pradaxa
With thousands of Pradaxa lawsuits alleging that patients suffered from problems with Pradaxa, one of the most common allegations involves the lack of an antidote. Many plaintiffs claim that the manufacturer failed to warn them that they could experience a serious bleeding complication if they took Pradaxa, as well as failed to inform them that there is no current reversal agent for the drug.
According to court documents, more than 2,000 Pradaxa lawsuits are pending in the U.S. District Court, Southern District of Illinois under Judge David Herndon. The claims have been consolidated into a multidistrict litigation for consolidate pre-trial proceedings. The first bellwether trial is scheduled to begin in September 2014 with the others scheduled through March 2015.
Contact the American Injury Attorney Group Today
Have you or someone you love experienced problems with Pradaxa such as internal bleeding or other life-threatening complications and would like to learn more about your legal rights? Contact the American Injury Attorney Group today to schedule a no-obligation consultation, at no cost to you. We can review your case and help you determine if you are eligible to seek damages for your injuries. We can also connect you with an affiliated attorney who can file your lawsuit and work to help you seek the compensation to which you may be entitled for emotional distress, pain and suffering, lost wages, medical expenses and more.